195 related articles for article (PubMed ID: 33722417)
21. Report on NRG Oncology and the GOG Foundation.
Alvarez RD
Gynecol Oncol; 2016 Mar; 140(3):381-2. PubMed ID: 26905435
[No Abstract] [Full Text] [Related]
22. Organization, function, and accomplishments of the Gynecologic Oncology Group.
Park RC; Hoskins WJ; Weiner JM
Cancer Invest; 2002; 20(5-6):787-92. PubMed ID: 12197237
[No Abstract] [Full Text] [Related]
23. Gynecologic Oncology Group (GOG) report.
Alvarez RD
Gynecol Oncol; 2011 May; 121(2):247-8. PubMed ID: 21392820
[No Abstract] [Full Text] [Related]
24. European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and industry partners - a new Model D for drug and medical device development.
Concin N; Ray-Coquard I; Glasspool RM; Braicu E; Farrelly L; Votan B; Mirza MR; Gonzalez Martin A; Vergote I; Pignata S
Int J Gynecol Cancer; 2020 Jun; 30(6):730-734. PubMed ID: 32404377
[No Abstract] [Full Text] [Related]
25. Demographic reporting and language exclusion in gynecologic oncology clinical trials.
Lee SS; Dinicu AI; Arthurs L; Shields D; Pothuri B; Lightfoot MDS
Am J Obstet Gynecol; 2024 Jan; 230(1):73.e1-73.e14. PubMed ID: 37751830
[TBL] [Abstract][Full Text] [Related]
26. The Gynecologic Oncology Group (GOG) Report.
Alvarez RD
Gynecol Oncol; 2013 Apr; 129(1):5-6. PubMed ID: 23638464
[No Abstract] [Full Text] [Related]
27. Integrating the Gynecologic Oncology Group and Gynecologic Cancer SPOREs--a square peg in a round hole or fits like a glove?
Alvarez RD; Gershenson DM
Gynecol Oncol; 2007 Apr; 105(1):1-2. PubMed ID: 17306869
[No Abstract] [Full Text] [Related]
28. Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice.
Rimel BJ; Burke WM; Higgins RV; Lee PS; Lutman CV; Parker L
Gynecol Oncol; 2015 May; 137(2):280-4. PubMed ID: 25735256
[TBL] [Abstract][Full Text] [Related]
29. The global impact of the Gynecologic Cancer InterGroup in enhancing clinical trials in ovarian cancer.
Bacon M; Kitchener H; Stuart GC; Vermorken JB;
Int J Gynecol Cancer; 2011 May; 21(4):746-9. PubMed ID: 21543935
[TBL] [Abstract][Full Text] [Related]
30. Clinical trials in gynecologic oncology: Past, present, and future.
Annunziata CM; Kohn EC
Gynecol Oncol; 2018 Feb; 148(2):393-402. PubMed ID: 29212614
[TBL] [Abstract][Full Text] [Related]
31. Strategies and goals: the future of the International Gynecologic Cancer Society: IGCS Presidential Address.
Berek JS
Int J Gynecol Cancer; 2010 Dec; 20(9):1434-9. PubMed ID: 21119361
[No Abstract] [Full Text] [Related]
32. Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.
Brooks SE; Carter RL; Plaxe SC; Basen-Engquist KM; Rodriguez M; Kauderer J; Walker JL; Myers TK; Drake JG; Havrilesky LJ; Van Le L; Landrum LM; Brown CL
Gynecol Oncol; 2015 Jul; 138(1):101-8. PubMed ID: 25937529
[TBL] [Abstract][Full Text] [Related]
33. The Gynecologic Oncology Group (GOG) Report — July 2013.
Alvarez R
Gynecol Oncol; 2013 Oct; 131(1):6-7. PubMed ID: 24228272
[No Abstract] [Full Text] [Related]
34. East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective.
Enomoto T; Okamoto A; Kim JH; Lai CH; Wu X; Kim YM
J Gynecol Oncol; 2023 Sep; 34(5):e86. PubMed ID: 37593814
[TBL] [Abstract][Full Text] [Related]
35. Update on Gynecologic Oncology Group (GOG) trials in ovarian cancer.
Ozols RF
Cancer Invest; 2004; 22 Suppl 2():11-20. PubMed ID: 15573741
[TBL] [Abstract][Full Text] [Related]
36. Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years.
Leath CA; Monk BJ
Gynecol Oncol; 2018 Sep; 150(3):391-397. PubMed ID: 29954593
[TBL] [Abstract][Full Text] [Related]
37. Gynecologic Oncology Group (GOG).
Gallup DG; Cella DF
J Natl Cancer Inst Monogr; 1996; (20):77-8. PubMed ID: 8750471
[No Abstract] [Full Text] [Related]
38. Fertility preserving management in gynecologic cancer patients: the need for centralization.
Kesic V; Rodolakis A; Denschlag D; Schneider A; Morice P; Amant F; Reed N
Int J Gynecol Cancer; 2010 Dec; 20(9):1613-9. PubMed ID: 21119372
[TBL] [Abstract][Full Text] [Related]
39. Clinical trial methodology in rare gynecologic tumor research: Strategies for success.
Brown J; Naumann RW; Brady WE; Coleman RL; Moore KN; Gershenson DM
Gynecol Oncol; 2018 Jun; 149(3):605-611. PubMed ID: 29699802
[TBL] [Abstract][Full Text] [Related]
40. NCTN clinical trial standardization for radiotherapy through IROC and CIRO.
Zou W; Geng H; Teo BK; Finlay J; Xiao Y
Med Phys; 2018 Oct; 45(10):e850-e853. PubMed ID: 30151925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
